Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-d-aspartate and AMPA receptors

Neuroscience

Volumn 81, Issue 1, 1997, Pages 23-31

  Gemignani, A ^a   Marchese, S ^a   Fontana, G ^a   Raiteri, M ^a  

^a 16148   (Italy)

Author keywords

AMPA receptors; Cultured hippocampal neurons; Neuropeptide Y release; NMDA receptors

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4,4 DIPHENYL 3 BUTENYL)GUVACINE; AMPA RECEPTOR; DIZOCILPINE; DIZOCILPINE MALEATE; GLUTAMINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROPEPTIDE Y;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; CELL CULTURE; DESENSITIZATION; FEEDING BEHAVIOR; HIPPOCAMPUS; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANTI-ANXIETY AGENTS; ANTIBODY SPECIFICITY; ANTIHYPERTENSIVE AGENTS; BENZODIAZEPINES; BENZOTHIADIAZINES; CALCIUM; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; KAINIC ACID; MAGNESIUM; NEURONS; NEUROPEPTIDE Y; QUINOXALINES; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; TETRODOTOXIN;

EID: 0030779061     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00168-1     Document Type: Article

References (66)

1. Allen Y. S., Adrian T. E., Allen J. M., Tatemoto K., Crow T. J., Bloom S. R., Polak J. M. Neuropeptide Y distribution in the rat brain. Science. 221:1983;877-879.
2. Aoki C., Pickel V. M. Neuropeptide Y in cortex and striatum: ultrastructural distribution and coexistence with classical neurotransmitters and neuropeptides. Ann. N. Y. Acad. Sci. 611:1990;186-205.
3. Beal M. F., Mazurek M. F., Chattha G. K., Svendsen C. N., Bird E. D., Martin J. B. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann. Neurol. 20:1986;282-288.
4. + and glutamate activates different neurotransmitter release mechanisms in GABAergic neurons: vesicular versus non-vesicular release of GABA. Neuroscience. 54:1993;1019-1034.
5. Ben Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
6. Bleakman D., Harrison N. L., Colmers W. F., Miller R. J. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmac. 107:1992;334-340.
7. Bliss T. V. P., Collingridge G. L. A synaptic model of memory-long term potentiation in the hippocampus. Nature. 361:1993;31-39.
8. Chan-Palay V. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia. J. comp. Neurol. 260:1987;201-223.
9. Colmers W. F., Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 17:1994;373-379.
10. 2 receptor. Br. J. Pharmac. 102:1991;41-44.
11. Colmers W. F., Lukowiak K., Pittman Q. J. Neuropeptide Y reduces orthodromically evoked population spike in rat hippocampal CA1 by a possibly presynaptic mechanism. Brain Res. 346:1985;404-408.
12. Davies C. A., Morroll D. R., Prinja D., Mann D. M. A., Gibbs A. A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease. J. neurol. Sci. 96:1990;59-73.
13. Dawbarn D., De Quidt M. E., Emson P. C. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res. 340:1985;251-260.
14. Deller T., Leranth C. Synaptic connections of neuropeptide Y (NPY) immunoreactive neurons in the hilar area of the rat hippocampus. J. comp. Neurol. 300:1990;433-447.
15. De Quidt M. E., Emson P. C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system - II. Immunohistochemical analysis. Neuroscience. 18:1986;545-618.
16. Dingledine R., McBain C. J., McNamara J. G. Excitatory amino acid receptors in epilepsy. Trends pharmac. Sci. 11:1990;334-338.
17. Dumont Y., Fournier A., St-Pierre S., Quirion R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci. 13:1993;73-86.
18. Dumont Y., Martel J. C., Fournier A., St. Pierre S., Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol. 38:1992;125-167.
19. 3H]aminobutyric acid release from cultured mouse cerebral cortex neurons by sulphur-containing excitatory amino acid transmitter candidates: receptor activation mediates two distinct mechanisms of release. J. Neurochem. 57:1991;1388-1397.
20. During M. J., Ryder K. M., Spencer D. D. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature. 376:1995;174-177.
21. Erickson J. C., Clegg K. E., Palmiter R. D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-418.
22. Fink K., Bönisch H., Göthert M. Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex. Eur. J. Pharmac. 185:1990;115-117.
23. Fitzgerald S. C. (1989) Dissociated spinal cord-dorsal root ganglion cultures on plastic tissue culture dishes and glass coverslips and wells. In A Dissection and Tissue Culture Manual of the Nervous System (eds Shahar A., de Vellis J., Vernadakis A. and Haber B.), pp. 219-222. Alan R. Liss, New York.
24. Flood J., Morley J. Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation. Peptides. 10:1989;963-966.
25. Fontana G., De Bernardi R., Ferro F., Gemignani A., Raiteri M. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons. J. Neurochem. 66:1996;161-168.
26. Gallo V., Kingsbury A., Balázs R., Jørgensen O. S. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J. Neurosci. 7:1987;2203-2213.
27. Gerald C., Walker M. W., Criscione L., Gustafson E. L., Batzl-Hartmann C., Smith K. E., Vaysse P., Durkin M. M., Laz T. M., Linemeyer D. L., Schaffhauser A. O., Whitebread S., Hofbauer K. G., Taber R. I., Branchek T. A., Weinshank R. L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
28. Gottfries C.-G., Frederiksen S. O., Heilig M. Neuropeptides and Alzheimer's disease. Eur. Neuropsychopharmac. 5:1995;491-500.
29. 2 receptors in rat hippocampal slices in vitro. Br. J. Pharmac. 113:1994;737-740.
30. Haas H. L., Hermann A., Greene R. W., Chan-Palay V. Action and location of neuropeptide tyrosine (Y) in hippocampal neurons of rat slice preparation. J. comp. Neurol. 257:1987;208-215.
31. 3H]GABA from hippocampal neurons in primary culture. Brain Res. 482:1989;23-33.
32. Heilig M., Koob G. F., Ekman R., Britton K. T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 17:1994;80-84.
33. Heilig M., Wahlestedt C., Ekman R., Widerlöv E. Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur. J. Pharmac. 147:1988;465-467.
34. Hendry J. H. C. (1993) Organization of neuropeptide Y neurons in the mammalian central nervous system. In The Biology of Neuropeptide Y and Related Peptides (eds Colmers W. F. and Wahlestedt C.), pp. 65-156. Humana Press, New Jersey.
35. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science. 252:1991;851-853.
36. Hollmann M., Heinemann S. Cloned glutamate receptors. A. Rev. Neurosci. 17:1994;31-108.
37. Hörtnagl H., Berger M. L., Sperk G., Pifl Ch. Regional heterogeneity in the distribution of neurotransmitter markers in the rat hippocampus. Neuroscience. 45:1991;261-272.
38. Kemp J. A., Foster A. C., Leeson P. D., Priestley T., Tridgett R., Iversen L. L., Woodruff G. N. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc. natn. Acad. Sci. U.S.A. 85:1988;6547-6550.
39. Köhler C., Eriksson L. G., Davies S., Chan-Palay V. Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J. comp. Neurol. 244:1986;384-400.
40. Kyrkouli S. E., Stanley B. G., Hutchinson R., Seirafi R. D., Leibowitz S. F. Peptide-amine interactions in the hypothalamic paraventricular nucleus: analysis of galanin and neuropeptide Y in relation to feeding. Brain Res. 521:1990;185-191.
41. Larhammar D., Söderberg C. and Blomquist A. G. (1993) Evolution of the neuropeptide family of peptides. In The Biology of Neuropeptide Y and Related Peptides (eds Colmers W. F. and Wahlestedt C.), pp. 1-41. Humana Press, New Jersey.
42. Manfridi A., Forloni G. L., Vezzani A., Forditto F., De Simoni M. G. Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons. Neuroscience. 41:1991;127-135.
43. Marksteiner J., Lassmann H., Saria A., Humpel C., Olenik C., Meyer D. K., Sperk G. Neuropeptide levels after pentylenetetrazol kindling in the rat. Eur. J. Neurosci. 2:1990;98-103.
44. Marksteiner J., Sperk G. Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decreased seizure threshold. Neuroscience. 26:1988;379-385.
45. Martignoni E., Blandini F., Petraglia F., Pacchetti C., Bono G., Nappi G. Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of Alzheimer type. J. neural Transm. 4:1992;191-205.
46. Marty S., Berninger B., Carroll P., Thoenen H. GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor. Neuron. 16:1996;565-570.
47. 2+ of NMDA responses in spinal cord neurones. Nature. 309:1984;261-263.
48. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends pharmac. Sci. 11:1990;379-387.
49. Milner T. A., Veznedaroglu E. Ultrastructural localization of neuropeptide Y-like immunoreactivity in the rat hippocampal formation. Hippocampus. 2:1992;107-126.
50. Paternain A. V., Morales M., Lerma J. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron. 14:1995;185-189.
51. Patneau D. K., Mayer M. L. Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron. 6:1991;785-798.
52. Pin J.-P., Bockaert J. Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J. Neurosci. 9:1989;648-656.
53. Pittaluga A., Raiteri M. Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur. J. Pharmac. 191:1990;231-234.
54. Pittaluga A., Raiteri M. N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J. Pharmac. exp. Ther. 260:1992;232-237.
55. Sadamatsu M., Kanai H., Masui A., Serikawa T., Yamada J., Sasa M., Kato N. Altered brain contents of neuropeptides in spontaneously epileptic rats (SER) and tremor rats with absence seizures. Life Sci. 30:1995;523-531.
56. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., Vezzani A. Lasting changes in somatostatin, neuropeptide Y, neurokinin B, cholecystokinin-immunoreactivity and their mRNA expression in kindling epileptogenesis. Brain Res. Rev. 22:1996;27-50.
57. Schwarzer C., Williamson J. M., Lothman E. W., Vezzani A., Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience. 69:1995;831-845.
58. Sperk G., Marksteiner J., Gruber B., Bellmann R., Mahata M., Ortler M. Functional changes in neuropeptide Y and somatostatin containing neurones induced by limbic seizures in the rat. Neuroscience. 50:1992;831-846.
59. Stenfors C., Mathé A. A., Theodorsson E. Repeated electroconvulsive stimuli: changes in neuropeptide Y, neurotensin and tachykinin concentrations in time. Prog. Neuropsychopharmacol. biol. Psychiat. 18:1994;201-209.
60. Stenfors C., Mathé A. A., Theodorsson E. Chromatographic and immunochemical characterization of rat brain neuropeptide Y-like immunoreactivity (NPY-LI) following repeated electroconvulsive stimuli. J. Neurosci. Res. 41:1995;206-212.
61. Tarnawa I., Farkas S., Berzsenyi P., Pataki A., Andrasi F. Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant, GYKI 52466. Eur. J. Pharmac. 167:1989;193-199.
62. Trussell L. O., Thio L. L., Zorumski C. F., Fischbach G. D. Rapid desensitization of glutamate receptors in vertebrate central neurons. Proc. natn. Acad. Sci. U.S.A. 85:1988;4562-4566.
63. Vezzani A., Civenni G., Rizzi M., Monno A., Messali S., Samanin R. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res. 660:1994;138-143.
64. Wahlestedt C., Blendy J. A., Kellar K. J., Heilig M., Widerlöv E., Ekman R. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y(NPY)-like immunoreactivity in the rat. Brain Res. 507:1990;65-68.
65. Wahlestedt C. and Heilig M. (1995) Neuropeptide Y and related peptides. In Psychopharmacology: The Fourth Generation of Progress (eds Bloom F. E. and Kupfer D. J.), pp. 543-551. Raven Press, New York.
66. Wahlestedt C., Pich E. M., Koob G. F., Yee F., Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science. 259:1993;528-531.